1型糖尿病成人客观睡眠质量与夜间血糖变异性的真实环境研究
该研究在家庭环境下同步使用客观睡眠监测设备与持续葡萄糖监测(CGM),对20名使用胰岛素泵的1型糖尿病成人进行最多15晚的配对观察,共分析170个夜晚。结果显示,在调整年龄、性别、BMI和夜间胰岛素剂量后,客观睡眠质量差与夜间血糖标准差(SD)和变异系数(CV)更高独立相关,提示睡眠质量可能参与1型糖尿病夜间血糖波动的调控。
要点
- 客观睡眠质量差与夜间血糖SD和CV升高独立相关。
- 睡眠质量与目标范围内时间及高、低血糖时间无显著关联。
- 个体内与个体间睡眠和血糖特征均存在较大变异。
核心结论
- 在1型糖尿病成人中,客观测量的睡眠质量与夜间血糖变异性相关,提示睡眠质量在夜间血糖控制中具有重要作用。
研究设计与样本
- 真实家庭环境下的观察性研究,纳入20名使用胰岛素泵的1型糖尿病成人(男女各10名),同步进行客观睡眠质量评估(Zmachine Insight+)与CGM,每人最多15晚,共分析170个夜晚。
主要发现
- 170晚中86晚(51%)为睡眠质量好,84晚(49%)为睡眠质量差。
- 采用线性混合效应模型,调整年龄、性别、BMI和夜间胰岛素剂量后,睡眠质量差与夜间血糖SD较高相关(系数0.39,95%CI 0.10–0.67,p=0.009)。
- 睡眠质量差与夜间血糖CV较高相关(系数4.35,95%CI 0.8–7.9,p=0.02)。
- 汇总数据与个体层面数据均显示睡眠质量差的夜晚SD和CV更大,睡眠质量好的夜晚SD和CV更小。
- 未发现睡眠质量与目标范围内时间或高于、低于目标范围时间存在关联。
关键数值与推荐
- 睡眠质量依据美国国家睡眠基金会共识标准,以睡眠效率、入睡后觉醒时间和觉醒次数三项客观睡眠特征组合判定为「好」或「差」。
- 血糖变异性以夜间CGM葡萄糖值的SD和CV量化。
- 参与者保留日常CGM报警设置,以反映真实生活状态。
临床怎么用
- 对使用胰岛素泵的1型糖尿病成人,可将睡眠质量纳入个体化血糖管理计划的考量。
- 夜间血糖波动较大的患者,可关注并评估其睡眠质量。
- 睡眠质量与目标范围内时间无显著关联,提示其影响主要体现在血糖离散程度而非达标时间。
局限性
- 样本量较小,仅20名成人且均为胰岛素泵使用者。
- 为观察性研究,无法确定睡眠质量与血糖变异性之间的因果关系。
- 研究在真实家庭环境中进行,未控制所有混杂因素,且个体间与个体内变异较大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Suboptimal subjective sleep quality is very common in adults with type 1 diabetes. Reducing glycaemic variability is a key objective in this population. To date, no prior studies have examined the associations between objectively measured sleep quality and overnight glycaemic variability in adults with type 1 diabetes. We aimed to test the hypothesis that poor sleep quality would be associated with greater overnight glycaemic variability. METHODS: Data were collected in the home setting from 20 adults (ten male and ten female participants) with type 1 diabetes who were current insulin pump users. Simultaneous assessments of objective sleep quality (Zmachine Insight+) and continuous glucose monitoring (CGM) were performed over multiple nights (up to 15 nights) in each participant. Due to the real-life nature of this study, the participants kept their usual CGM alerts for out-of-range glucose values. Sleep quality was categorised as 'good' or 'poor' using a composite of objective sleep features (i.e. sleep efficiency, wake after sleep onset and number of awakenings) based on the National Sleep Foundation's consensus criteria. Glycaemic variability was quantified using SD and CV of overnight glucose values based on overnight CGM profiles. RESULTS: A total of 170 nights were analysed. Overall, 86 (51%) nights were categorised as good sleep quality, and 84 (49%) nights were categorised as poor sleep quality. Using linear mixed-effects models, poor sleep quality was significantly associated with greater glycaemic variability as quantified by SD (coefficient: 0.39 [95% CI 0.10, 0.67], p = 0.009) and CV (coefficient: 4.35 [95% CI 0.8, 7.9], p = 0.02) of overnight glucose values, after accounting for age, sex, BMI and overnight insulin dose. There was large inter- and intra-individual variability in sleep and glycaemic characteristics. Both pooled and individual-level data revealed that the nights with poor sleep quality had larger SDs and CVs, and, conversely, the nights with good sleep quality had smaller SDs and CVs. No associations were found between sleep quality and time spent in the target glucose range, or above or below the target glucose range, where CGM alarms are most likely to occur. CONCLUSIONS/INTERPRETATION: Objectively measured sleep quality is associated with overnight glycaemic variability in adults with type 1 diabetes. These findings highlight an important role of sleep quality in overnight glycaemic control in type 1 diabetes. They also provide a strong incentive to both patients and healthcare providers for considering sleep quality in personalised type 1 diabetes glycaemic management plans. Future studies should investigate the mechanisms linking sleep quality to glycaemic variability.
引用
- Brandt R, Park M, Wroblewski K, et al. Sleep quality and glycaemic variability in a real-life setting in adults with type 1 diabetes. Diabetologia. 2021. PMID: 34136937. doi:10.1007/s00125-021-05500-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。